ACT (Advanced Cardiac Therapeutics) is developing an innovative irrigated cardiac catheter ablation system that will enable tissue temperature measurement during the application of radiofrequency energy.

This permits Electro-Physiologists greater control in their lesion creation and has the potential to improve patient outcomes.

Headquarters
USA

INVESTMENT DATE
January 2010

INVESTMENT THESIS
Venture-stage investment in medical technology

STATUS
Current

INDUSTRY
Cardiovascular

STAGE CAPITAL TEAM
Aris Constantinides